dr. N. (Niels) Eijkelkamp - UMC Utrecht

lt;p>Niels Eijkelkamp (18-07-1980) is PI at the laboratory of translational immunology. His research focusses on chronic pain, a major debilitating disease that affects &gt;20% of the population. He aims to unravel mechanisms and to identify novel treatments of chronic pain by elucidating the role of the immune system and its interactions with the nervous system in chronic pain. His group is one of the very few groups in the Netherlands studying the mechanisms underlying pain. </p> <p>His group uses different experimental approaches to unravel molecular pain mechansims and identify novel treatment approaches with the ultimate aim to translate these basic research findings to chronic pain patients such as children with Juvenile Idiopathic arthritis and adults with chronic inflammatory disease and osteoarthtis.</p> <p>Eijkelkamp graduated in 2003 with honors in Medical Biology (University of Utrecht). In 2009 he completed his PhD under supervision of Dr. Heijnen with his thesis entitled ‘GRK gatekeeper of pain and inflammation’. Prior to his PhD he worked for 1 year on stress and wound healing in the team led by Dr. Sheridan at the Ohio State University. As PostDoc he had a joint appointment at the UMCU and University of Illinois at Urbana-Champaign to work on the role of GRKs in pain. Finally, he worked for 2 years on sensory transduction and signalling pathways in chronic pain in the laboratory of Dr. Wood at the University College London. Since 2013 he started his own group at the UMCU.</p>

Team van onderzoekers werkt aan volgende fase medicijn synerkine • ReumaNederland

Child Health: science for life - UMC Utrecht

Macrophages transfer mitochondria to sensory neurons to resolve inflammatory pain - ScienceDirect

FCE Directory - FOCIS

Cytokine receptor clustering in sensory neurons with an engineered cytokine fusion protein triggers unique pain resolution pathways

Macrophages transfer mitochondria to sensory neurons to resolve inflammatory pain

Anti-GD2 IgA kills tumors by neutrophils without antibody-associated pain in the preclinical treatment of high-risk neuroblastoma

Child Health magazine

FCE Directory - FOCIS

Veel moleculair onderzoek beloond met Vici-beurs, Nieuws

Study unravels molecular basis of chronic pain transition

Cells, Free Full-Text

Nico WULFFRAAT, Head of Department Pediatric immunology, Prof MD, University Medical Center Utrecht, Utrecht, UMC Utrecht, Division of Pediatrics

Sialic Acid-Engineered IL4–10 Fusion Protein is Bioactive and Rapidly Cleared from the Circulation

Ellis heeft chronische pijn door gordelroos: 'Voor mij komt vaccinatiecampagne te laat', Lifestyle